You are currently browsing the daily archive for March 20, 2025.
The Tesla backlash of March 2025 and the Bud Light controversy of 2023 both ignited swift, ideologically charged consumer reactions amplified by social media. Bud Light’s woes began with a Dylan Mulvaney ad, sparking a conservative boycott that cratered sales by up to 26%, while Tesla’s stem from Elon Musk’s Trump ties, alienating liberals and moderates as its stock plummeted over 40%. Both cases show how fast brand loyalty can erode when politics collide with commerce.
Yet, the responses differ sharply in tone and tactics. Bud Light faced a peaceful, effective boycott—think Kid Rock’s viral gunplay—focused on wallets, not violence, with sales dipping hard but stabilizing later. Tesla’s backlash has veered into chaos, with arson and vandalism targeting cars and dealerships, reflecting a rawer fury possibly fueled by Musk’s outsized persona and Tesla’s physical presence as a punching bag. The right shunned Bud Light; the left now torches Tesla.
Bud Light retreated, tweaking its image to appease critics, while Musk doubles down, flaunting Teslas at the White House amid Trump’s support. The beer brand took a hit but survived as a commodity; Tesla’s premium status and Musk’s defiance make its crisis more existential, blending economic rejection with a destructive edge. These sagas reveal how political tribalism can punish brands—one with a cold shoulder, the other with Molotovs.

Anne Fausto-Sterling’s claim that 1.7% of live births are intersex, popularized in her 2000 book Sexing the Body and a paper by Blackless et al., sounds compelling—until you peek under the hood. She argues it shows sex isn’t binary, estimating 1 in 59 babies has some “nondimorphic sexual development.” But this number isn’t what it seems. It’s a classic case of “cooking definitions”—stretching the term “intersex” so wide it loses meaning, inflating the stats to fit a narrative. Let’s break down how she did it and why it’s misleading.
Fausto-Sterling’s team cast a net over every condition deviating from a textbook male (XY, penis, testes) or female (XX, vagina, ovaries). They counted late-onset congenital adrenal hyperplasia (LOCAH)—1.5% of births—as intersex, despite these babies being born clearly male or female with matching chromosomes. LOCAH might cause later issues like excess hair, but it’s not ambiguous; most never need sex reassignment. Tossing in 88% of her 1.7% from this alone smells like padding the books to hit a target.
Then there’s Klinefelter Syndrome (XXY, 0.1%) and Turner Syndrome (X0, 0.05%). Klinefelter folks are phenotypically male—penis, testes, often fertile until puberty—and Turner folks are female—vagina, uterus, just with ovarian quirks. Neither has ambiguous genitals or mismatched sex; they’re not “intersex” by clinical standards. Fausto-Sterling also includes vaginal agenesis (0.016%), where XX females lack a vagina but have normal ovaries—hardly unclassifiable. This isn’t intersex; it’s a grab-bag of differences of sex development (DSDs).
Leonard Sax shredded this in 2002 in Journal of Sex Research. He argued “intersex” should mean chromosomal sex (XX/XY) clashing with phenotype or truly ambiguous genitals—think ovotestes or severe CAH needing surgery. By that definition, intersex drops to 0.018%—1 in 5,500 births—matching what neonatologists see (1 in 1,500–2,000 for ambiguous cases). Sax’s critique shows Fausto-Sterling’s 1.7% isn’t wrong data; it’s a definitional sleight-of-hand, lumping in conditions no doctor flags as intersex at birth.
So, when someone touts 1.7% to argue sex is a spectrum, point to the cooking: Fausto-Sterling broadened “intersex” beyond reason, counting non-ambiguous cases to juice the number. It’s not fabricated—her prevalence rates trace to real studies—but it’s misleading, designed to push a point rather than reflect reality. The true intersex rate, where sex is unclear, is closer to 0.05% or less. Next time that stat drops, you’ve got the recipe to call out the fudge.





Your opinions…